NDC 51167-500 – Orkambi
Lumacaftor 150 mg/1; Ivacaftor 188 mg/1 · Granule · Oral
Product NDC51167-500
Product details
- Brand name
- Orkambi
- Generic name
- Lumacaftor and ivacaftor
- Labeler
- Vertex Pharmaceuticals Incorporated
- Dosage form
- Granule
- Route
- Oral
- Marketing category
- NDA · NDA211358
- Marketed since
- August 7, 2018
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
Active ingredients
- Lumacaftor 150 mg/1
- Ivacaftor 188 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 51167-500-02 | 56 PACKET in 1 CARTON (51167-500-02) / 1 GRANULE in 1 PACKET | Aug 7, 2018 |
Other Orkambi products
- 51167-122 Lumacaftor 75 mg/1; Ivacaftor 94 mg/1 · Granule · Vertex Pharmaceuticals Incorporated
- 51167-900 Lumacaftor 100 mg/1; Ivacaftor 125 mg/1 · Granule · Vertex Pharmaceuticals Incorporated
- 51167-700 Lumacaftor 100 mg/1; Ivacaftor 125 mg/1 · Tablet, Film Coated · Vertex Pharmaceuticals Incorporated
- 51167-809 Lumacaftor 200 mg/1; Ivacaftor 125 mg/1 · Tablet, Film Coated · Vertex Pharmaceuticals Incorporated